BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 33948082)

  • 21. Anti-Interleukin-17s for successful management of pustular psoriasis.
    Guerra P; Rosi E; Scandagli I; Silvi G; Nunziati G; Di Cesare A; Prignano F
    Cytokine; 2023 Nov; 171():156353. PubMed ID: 37672865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acrodermatitis continua of Hallopeau: historical perspectives and modern management.
    Bhate C; Schwartz RA
    Ital J Dermatol Venerol; 2022 Apr; 157(2):132-136. PubMed ID: 35391533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of acrodermatitis continua of Hallopeau associated with generalized arthritis.
    Okuno H; Ogura K; Okuyama R; Itoi E
    Acta Dermatovenerol Croat; 2013; 21(4):265-7. PubMed ID: 24476617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.
    Gisondi P; Bellinato F; Girolomoni G
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review.
    Chen P; Li C; Xue R; Chen H; Tian X; Zeng K; Zhang X; Liang J
    J Dermatolog Treat; 2018 Jun; 29(4):353-363. PubMed ID: 29098909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
    Shi L; Zeng L; Huang X; Wang B; Zhang Y; Zhang G
    Clin Cosmet Investig Dermatol; 2023; 16():951-957. PubMed ID: 37051587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau.
    Rizzetto G; Diotallevi F; Molinelli E; Radi G; Offidani AM
    Skin Appendage Disord; 2022 Mar; 8(2):146-149. PubMed ID: 35419415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature.
    Kołt-Kamińska M; Żychowska M; Reich A
    Biologics; 2021; 15():317-327. PubMed ID: 34393480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.
    Smirnova LM; Vertieva EY; Olisova OY; Anpilogova EM
    Biologics; 2019; 13():83-87. PubMed ID: 31190732
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
    Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E
    SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pustular Psoriasis: From Pathophysiology to Treatment.
    Genovese G; Moltrasio C; Cassano N; Maronese CA; Vena GA; Marzano AV
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report.
    Alorainy M; Alshaya M; Al-Rikabi A; Ayesh M; Alsaif F
    Case Rep Dermatol; 2017; 9(3):259-264. PubMed ID: 29422844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and clinical features of pustular psoriasis: A 15-year retrospective cohort.
    Tosukhowong T; Kiratikanon S; Wonglamsam P; Netiviwat J; Innu T; Rujiwetpongstorn R; Tovanabutra N; Chiewchanvit S; Kwangsukstith C; Chuamanochan M
    J Dermatol; 2021 Dec; 48(12):1931-1935. PubMed ID: 34532894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.